AJP - Gastrointestinal and Liver Physiology, Vol 271, Issue 5 841-G848, Copyright © 1996 by American Physiological Society

ARTICLES

Products of enteropathogenic E. coli inhibit lymphokine production by gastrointestinal lymphocytes

J. M. Klapproth, M. S. Donnenberg, J. M. Abraham and S. P. James
Department of Medicine, School of Medicine, University of Maryland at Baltimore, USA.

Previously we have shown that lysates of enteropathogenic Escherichia coli (EPEC) inhibit lymphokine production by mitogen-activated peripheral blood mononuclear cells (PBMCs). The aim of the present study was to determine whether products of EPEC alter lymphokine expression by gastrointestinal mucosal lymphocytes. Lysates from EPEC clones inhibited mitogen-stimulated interleukin-2 (IL-2), IL-4, IL-5, and interferon-gamma (IFN-gamma) but not IL-8 mRNA expression by lamina propria mononuclear cells isolated from surgically resected colon specimens. Inhibitory lysates did not significantly change CD25 expression on either CD4, CD8, or CD45R0 lymphocytes by flow cytometry. Bacterial supernatants of EPEC inhibited IL-2 and IL-5 protein secretion by mitogen-stimulated PBMCs. EPEC lysates inhibited IL-2 mRNA expression induced by lysates of nonpathogenic E. coli. In conclusion, EPEC contains a novel gene(s) that encodes factors that selectively inhibit IL-2, IL-4, IL-5, and IFN-gamma expression by mucosal mononuclear cells without affecting CD25 or IL-8 expression. Thus enteric bacteria can produce factors that may regulate the function of the gastrointestinal mucosal immune system.

This article has been cited by other articles:

				M. P. Stevens, P. M. van Diemen, F. Dziva, P. W. Jones, and T. S. Wallis Options for the control of enterohaemorrhagic Escherichia coli in ruminants Microbiology, December 1, 2002; 148(12): 3767 - 3778. [Full Text] [PDF]

				B. A. Vallance, W. Deng, M. De Grado, C. Chan, K. Jacobson, and B. B. Finlay Modulation of Inducible Nitric Oxide Synthase Expression by the Attaching and Effacing Bacterial Pathogen Citrobacter rodentium in Infected Mice Infect. Immun., November 1, 2002; 70(11): 6424 - 6435. [Abstract] [Full Text] [PDF]

				M. P. Stevens, P. M. van Diemen, G. Frankel, A. D. Phillips, and T. S. Wallis Efa1 Influences Colonization of the Bovine Intestine by Shiga Toxin-Producing Escherichia coli Serotypes O5 and O111 Infect. Immun., September 1, 2002; 70(9): 5158 - 5166. [Abstract] [Full Text] [PDF]

				F. Meyer, K. T. Wilson, and S. P. James Modulation of Innate Cytokine Responses by Products of Helicobacter pylori Infect. Immun., November 1, 2000; 68(11): 6265 - 6272. [Abstract] [Full Text] [PDF]

				J.-M. A. Klapproth, I. C. A. Scaletsky, B. P. McNamara, L.-C. Lai, C. Malstrom, S. P. James, and M. S. Donnenberg A Large Toxin from Pathogenic Escherichia coli Strains That Inhibits Lymphocyte Activation Infect. Immun., April 1, 2000; 68(4): 2148 - 2155. [Abstract] [Full Text] [PDF]

				S. Fournout, C. M. Dozois, M. Odin, C. Desautels, S. Peres, F. Herault, F. Daigle, C. Segafredo, J. Laffitte, E. Oswald, et al. Lack of a Role of Cytotoxic Necrotizing Factor 1 Toxin from Escherichia coli in Bacterial Pathogenicity and Host Cytokine Response in Infected Germfree Piglets Infect. Immun., February 1, 2000; 68(2): 839 - 847. [Abstract] [Full Text] [PDF]

				D. R. Mack, S. Michail, S. Wei, L. McDougall, and M. A. Hollingsworth Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G941 - G950. [Abstract] [Full Text] [PDF]